Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:22 pm Purchase | 2026-06-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | BIOTECHNOLOGY VALUE FUND L P | 3,110,363 9.990% | 1,201,641![]() (+62.96%) | Filing History |
| 2026-08-14 4:19 pm Purchase | 2026-06-30 | 13G | TSCAN THERAPEUTICS INC TCRX | BIOTECHNOLOGY VALUE FUND L P | 6,417,831 9.990% | 839,543![]() (+15.05%) | Filing History |
| 2026-08-14 4:18 pm Sale | 2026-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | BIOTECHNOLOGY VALUE FUND L P | 672,789 4.700% | -206,220![]() (-23.46%) | Filing History |
| 2026-08-14 4:15 pm Purchase | 2026-06-30 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BIOTECHNOLOGY VALUE FUND L P | 3,235,778 8.000% | 1,100,870![]() (+51.57%) | Filing History |
| 2026-08-14 4:13 pm Sale | 2026-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | BIOTECHNOLOGY VALUE FUND L P | 2,391,075 7.100% | -461,623![]() (-16.18%) | Filing History |
| 2026-08-14 4:10 pm Purchase | 2026-06-30 | 13G | INVIVYD, INC. IVVD | BIOTECHNOLOGY VALUE FUND L P | 29,571,826 9.990% | 4,046,826![]() (+15.85%) | Filing History |
| 2026-08-14 4:08 pm Purchase | 2026-06-30 | 13G | IMAGENEBIO, INC. IMA | BIOTECHNOLOGY VALUE FUND L P | 1,128,647 9.900% | 18,645![]() (+1.68%) | Filing History |
| 2026-08-14 4:06 pm Purchase | 2026-06-30 | 13G | CULLINAN THERAPEUTICS INC CGEM | BIOTECHNOLOGY VALUE FUND L P | 6,491,123 9.990% | 329,654![]() (+5.35%) | Filing History |
| 2026-08-14 4:01 pm Purchase | 2026-06-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | BIOTECHNOLOGY VALUE FUND L P | 2,801,545 5.300% | 453,700![]() (+19.32%) | Filing History |
| 2026-08-12 4:55 pm Purchase | 2026-08-05 | 13G | TCGX Acquisition Corp. TCGX | BIOTECHNOLOGY VALUE FUND L P | 500,000 5.500% | 500,000![]() (New Position) | Filing History |
| 2026-08-04 7:07 pm Purchase | 2026-07-28 | 13D | ENTERA BIO LTD SHS ENTX | BIOTECHNOLOGY VALUE FUND L P | 17,225,121 9.990% | 17,225,121![]() (New Position) | Filing History |
| 2026-07-20 6:22 pm Purchase | 2026-07-13 | 13G | RESEARCH ALLIANCE CORP IV RACD | BIOTECHNOLOGY VALUE FUND L P | 500,000 6.400% | 500,000![]() (New Position) | Filing History |
| 2026-07-16 5:00 pm Sale | 2026-07-14 | 13D | XOMA ROYALTY CORPORATION COMMO XOMA | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -7,593,303![]() (Position Closed) | Filing History |
| 2026-07-10 4:07 pm Purchase | 2026-07-02 | 13G | PYXIS ONCOLOGY INC PYXS | BIOTECHNOLOGY VALUE FUND L P | 8,336,902 9.990% | 8,336,902![]() (New Position) | Filing History |
| 2026-06-29 5:20 pm Unchanged | 2026-06-25 | 13D | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | BIOTECHNOLOGY VALUE FUND L P | 16,001,284 19.700% | 0 (Unchanged) | Filing History |
| 2026-06-26 6:43 pm Sale | 2026-06-26 | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 5,237,151 6.300% | -1,630,658![]() (-23.74%) | Filing History |
| 2026-06-04 5:06 pm Purchase | 2026-05-28 | 13G | Q32 BIO INC QTTB | BIOTECHNOLOGY VALUE FUND L P | 2,367,524 9.990% | 2,367,524![]() (New Position) | Filing History |
| 2026-05-29 5:51 pm Purchase | 2026-05-21 | 13G | RESEARCH ALLIANCE CORP III CL RACC | BIOTECHNOLOGY VALUE FUND L P | 500,000 6.400% | 500,000![]() (New Position) | Filing History |
| 2026-05-27 4:37 pm Purchase | 2026-05-19 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | BIOTECHNOLOGY VALUE FUND L P | 2,134,908 5.300% | 2,134,908![]() (New Position) | Filing History |
| 2026-05-18 5:26 pm Purchase | 2026-05-14 | 13D | XOMA ROYALTY CORPORATION COMMO XOMA | BIOTECHNOLOGY VALUE FUND L P | 7,593,303 43.300% | 5,003,000![]() (+193.14%) | Filing History |

